Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.
Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Riccardo Dalla‐Favera(Columbia University), Antonino Neri(University of Milan), Vittorio Tassi(Casa Sollievo della Sofferenza), Rossella Calori(IRCCS Policlinico San Donato), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Luca Baldini(University of Milan), Elizabeth W. Newcomb(New York University), Jerry Z. Gong(Columbia University)
PubMed
June 1, 1994
Cited by 75
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
|Nature Immunology|2006|771